Impact of metformin monotherapy versus metformin with oestrogen- progesterone on lipids in adolescent girls with polycystic ovarian syndrome

Clinical Endocrinology

Volumn 79, Issue 2, 2013, Pages 199-203

  Bredella, Miriam A ^a   McManus, Shilpa ^a   Misra, Madhusmita ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ETHINYLESTRADIOL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE ESCALATION; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ESTROGENS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; METFORMIN; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84880047808     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12028     Document Type: Article

References (25)

1. Geller, D.H., Pacaud, D., Gordon, C.M., et al,. (2011) State of the art review: emerging therapies: the use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS). International Journal of Pediatric Endocrinology, 2011, 9.
2. Arslanian, S.A., Lewy, V., Danadian, K., et al,. (2002) Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. Journal of Clinical Endocrinology and Metabolism, 87, 1555-1559.
3. Hoeger, K., Davidson, K., Kochman, L., et al,. (2008) The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. Journal of Clinical Endocrinology and Metabolism, 93, 4299-4306.
4. Bekx, M.T., Connor, E.C., &, Allen, D.B., (2010) Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. Journal of Pediatric and Adolescent Gynecology, 23, 7-10.
5. Givens, J.R., Andersen, R.N., Wiser, W.L., et al,. (1974) Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive. Journal of Clinical Endocrinology and Metabolism, 38, 727-735.
6. Mastorakos, G., Koliopoulos, C., &, Creatsas, G., (2002) Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertility and Sterility, 77, 919-927.
7. Mastorakos, G., Koliopoulos, C., Deligeoroglou, E., et al,. (2006) Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertility and Sterility, 85, 420-427.
8. Baillargeon, J.P., McClish, D.K., Essah, P.A., et al,. (2005) Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 90, 3863-3870.
9. Khader, Y.S., Rice, J., John, L., et al,. (2003) Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception, 68, 11-17.
10. Burkman, R.T., (2003) Hormone replacement therapy. Current controversies. Minerva Ginecologica, 55, 107-116.
11. Keeling, D., (2003) Combined oral contraceptives and the risk of myocardial infarction. Annals of Medicine, 35, 413-418.
12. Nestler, J.E., Jakubowicz, D.J., de Vargas, A.F., et al,. (1998) Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. Journal of Clinical Endocrinology and Metabolism, 83, 2001-2005.
13. Checa, M.A., Requena, A., Salvador, C., et al,. (2005) Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome. Human Reproduction Update, 11, 375-390.
14. Kashyap, S., Wells, G.A., &, Rosenwaks, Z., (2004) Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Human Reproduction, 19, 2474-2483.
15. La Marca, A., Artensio, A.C., Stabile, G., et al,. (2005) Metformin treatment of PCOS during adolescence and the reproductive period. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 121, 3-7.
16. la Marca, A., Egbe, T.O., Morgante, G., et al,. (2000) Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome. Human Reproduction, 15, 21-23.
17. Lord, J.M., Flight, I.H., &, Norman, R.J., (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ, 327, 951-953.
18. Velazquez, E.M., Mendoza, S., Hamer, T., et al,. (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism, 43, 647-654.
19. Ibanez, L., Jaramillo, A.M., Ferrer, A., et al,. (2005) High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception. Human Reproduction, 20, 2457-2462.
20. Morin-Papunen, L., Rautio, K., Ruokonen, A., et al,. (2003) Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88, 4649-4654.
21. Rasouli, N., Raue, U., Miles, L.M., et al,. (2005) Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue. American Journal of Physiology. Endocrinology and Metabolism, 288, E930-E934.
22. Ibanez, L., &, de Zegher, F., (2004) Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. Journal of Clinical Endocrinology and Metabolism, 89, 1592-1597.
23. Ibanez, L., &, de Zegher, F., (2006) Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women. Human Reproduction Update, 12, 243-252.
24. De Leo, V., Musacchio, M.C., Morgante, G., et al,. (2006) Metformin treatment is effective in obese teenage girls with PCOS. Human Reproduction, 21, 2252-2256.
25. Glueck, C.J., Morrison, J.A., Friedman, L.A., et al,. (2006) Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism, 55, 508-514.